<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01157702</url>
  </required_header>
  <id_info>
    <org_study_id>721001</org_study_id>
    <secondary_id>2010-020026-17</secondary_id>
    <nct_id>NCT01157702</nct_id>
  </id_info>
  <brief_title>Yearly Strain Variation Study, 2010/2011</brief_title>
  <official_title>An Open-Label Phase 3 Study to Assess the Immunogenicity and Safety of a Vero Cell-Derived Trivalent Seasonal Influenza Vaccine, Strain Composition 2010/2011, in an Adult and Elderly Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ology Bioservices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ology Bioservices</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to verify the immunogenicity and tolerance of a trivalent&#xD;
      seasonal influenza vaccine with strain composition according to WHO/EU recommendation for the&#xD;
      2010/2011 season for yearly licensing application.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the immunogenicity to each of the three antigens contained in a trivalent seasonal influenza vaccine with strain composition according to WHO/EU recommendation for the 2010/2011 season in an adult and elderly population</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Influenza</condition>
  <condition>Seasonal Influenza</condition>
  <arm_group>
    <arm_group_label>Vaccine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vaccination with one dose (0.5 mL) of inactivated influenza vaccine</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Inactivated influenza vaccine (split virus, Vero cell-derived)</intervention_name>
    <description>One 0.5 mL dose of inactivated influenza vaccine in a pre-filled syringe, administered by intramuscular injection into the musculus deltoideus in the upper arm</description>
    <arm_group_label>Vaccine</arm_group_label>
    <other_name>Preflucel</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is 18 to 59 years of age, inclusive, at the time of screening (for Stratum A&#xD;
             only)&#xD;
&#xD;
          -  Subject is 60 years of age or older, inclusive, at the time of screening (for Stratum&#xD;
             B only)&#xD;
&#xD;
          -  Subject has given written informed consent prior to study entry&#xD;
&#xD;
          -  Subject is generally healthy, as determined by the investigator's clinical judgment&#xD;
             through collection of medical history and performance of a physical examination, such&#xD;
             that the investigator would not hesitate to provide routine influenza immunization to&#xD;
             the subject in the course of routine medical practice&#xD;
&#xD;
          -  Subject agrees to keep a daily record of symptoms for the duration of the study&#xD;
&#xD;
          -  If subject is of childbearing potential, subject presents with a negative urine&#xD;
             pregnancy test, and agrees to employ adequate birth control measures for the duration&#xD;
             of the study&#xD;
&#xD;
          -  Subject is willing and able to comply with the requirements of the protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject has a history of severe allergic reaction or anaphylaxis&#xD;
&#xD;
          -  Subject has an oral temperature of &gt;= 37.5°C on the day of vaccination in this study.&#xD;
&#xD;
          -  Subject has a rash or dermatologic condition or tattoos, which may interfere with&#xD;
             injection site reaction rating&#xD;
&#xD;
          -  Subject has received a live vaccine within 4 weeks or an inactivated or subunit&#xD;
             vaccine within 2 weeks of study entry&#xD;
&#xD;
          -  Subject has received a seasonal influenza vaccine within 6 months of study entry&#xD;
&#xD;
          -  Subject currently has or had a history of a significant neurological, cardiovascular,&#xD;
             pulmonary (including asthma), hepatic, metabolic, rheumatic, autoimmune, hematological&#xD;
             or renal disorder&#xD;
&#xD;
          -  Subject has any inherited or acquired immunodeficiency&#xD;
&#xD;
          -  Subject has a disease or is currently undergoing a form of treatment or was undergoing&#xD;
             a form of treatment within 30 days prior to study entry that can be expected to&#xD;
             influence immune response. Such treatment includes, but is not limited to, systemic or&#xD;
             high dose inhaled (&gt;800 µg/day of beclomethasone dipropionate or equivalent)&#xD;
             corticosteroids, radiation treatment or other immunosuppressive or cytotoxic drugs.&#xD;
&#xD;
          -  Subject has a functional or surgical asplenia&#xD;
&#xD;
          -  Subject has a known or suspected problem with alcohol or drug abuse&#xD;
&#xD;
          -  Subject is a member of the team conducting this study or is in a dependent&#xD;
             relationship with one of the study team members. Dependent relationships include close&#xD;
             relatives (i.e., children, partner/spouse, siblings, parents) as well as employees of&#xD;
             the investigator or site personnel conducting the study.&#xD;
&#xD;
          -  Subject is pregnant or lactating at the time of enrollment&#xD;
&#xD;
          -  Subject has participated in another clinical study involving an investigational&#xD;
             product (IP) or investigational device within 30 days prior to enrollment or is&#xD;
             scheduled to participate in another clinical study involving an IP or investigational&#xD;
             device during the course of this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Clinic for Clinical Pharmacology, General Hospital Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>July 6, 2010</study_first_submitted>
  <study_first_submitted_qc>July 6, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2010</study_first_posted>
  <last_update_submitted>October 19, 2020</last_update_submitted>
  <last_update_submitted_qc>October 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

